90 related articles for article (PubMed ID: 8658759)
1. Clinical outcome of anti-HCV(+) renal allograft recipients.
Lee SW; Kang SW; Choi KH; Han KH; Lee HY; Han DS; Kim YS; Park K
Transplant Proc; 1996 Jun; 28(3):1501-2. PubMed ID: 8658759
[No Abstract] [Full Text] [Related]
2. Results of kidney transplantation in HBsAG and anti-HCV seropositive renal allograft recipients.
Durlik M; Gaciong Z; Soluch L; Rowińska D; Kozłowska-Boszko B; Rowiński W; Szmidt J; Lao M
Transplant Proc; 1996 Dec; 28(6):3459-60. PubMed ID: 8962347
[No Abstract] [Full Text] [Related]
3. Impact of presence of HBs antigen and anti-hepatitis C virus and anti-cytomegalovirus antibodies on transplanted kidney survival.
Sieńko J; Wiśniewska M; Ciechanowski K; Rózański J; Domański L; Myslak M; Kamiński M; Sulikowski T; Pabisiak K; Romanowski M; Mizerski A; Tejchman K; Nowacki M; Ostrowski M; Bohatyrewicz R
Transplant Proc; 2006; 38(1):136-8. PubMed ID: 16504685
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C, acute humoral rejection, and renal allograft survival.
Forman JP; Tolkoff-Rubin N; Pascual M; Lin J
J Am Soc Nephrol; 2004 Dec; 15(12):3249-55. PubMed ID: 15579529
[TBL] [Abstract][Full Text] [Related]
5. Long-term evolution of anti-HCV-positive renal transplant recipients.
Aroldi A; Lampertico P; Elli A; Lunghi G; Tarantino A; Montagnino G; Colombo M; Ponticelli C
Transplant Proc; 1998 Aug; 30(5):2076-8. PubMed ID: 9723397
[No Abstract] [Full Text] [Related]
6. Patient and graft survival of kidney allograft recipients with minimal hepatitis C virus infection: a case-control study.
Shahbazian H; Hajiani E; Ehsanpour A
Urol J; 2008; 5(3):178-83. PubMed ID: 18825625
[TBL] [Abstract][Full Text] [Related]
7. Impact of HCV infection on first cadaveric renal transplantation, a single center experience.
Lin HH; Huang CC; Huang JY; Yang CW; Wu MS; Fang JT; Yu CC; Chiang YJ; Chu SH
Clin Transplant; 2004 Jun; 18(3):261-6. PubMed ID: 15142046
[TBL] [Abstract][Full Text] [Related]
8. Impact of hepatitis C virus on renal transplantation: association with poor survival.
Pedroso S; Martins L; Fonseca I; Dias L; Henriques AC; Sarmento AM; Cabrita A
Transplant Proc; 2006; 38(6):1890-4. PubMed ID: 16908314
[TBL] [Abstract][Full Text] [Related]
9. Different impacts of hepatitis B virus and hepatitis C virus on the outcome of kidney transplantation.
Ingsathit A; Thakkinstian A; Kantachuvesiri S; Sumethkul V
Transplant Proc; 2007 Jun; 39(5):1424-8. PubMed ID: 17580153
[TBL] [Abstract][Full Text] [Related]
10. Clinical course of hepatitis C virus infection in renal transplant recipients.
Savas N; Ocal S; Colak T; Karakayali H; Yilmaz U; Haberal M
Transplant Proc; 2007 May; 39(4):984-6. PubMed ID: 17524869
[TBL] [Abstract][Full Text] [Related]
11. Risk of chronic liver disease in HBsAG and/or anti-HCV-positive renal allograft recipients.
Durlik M; Gaciong Z; Soluch L; Walecka-Zielecka B; Rancewicz Z; Rowińska D; Rowiński W; Szmidt J; Lao M
Transplant Proc; 1996 Feb; 28(1):50-1. PubMed ID: 8644327
[No Abstract] [Full Text] [Related]
12. Proteinuria after kidney transplantation: its relation to hepatitis C virus and graft outcome.
Sabry A; Hassan R; Mahmoud I; Hamed M; Sobh M
Iran J Kidney Dis; 2007 Oct; 1(2):88-97. PubMed ID: 19363283
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C in kidney transplant patients.
Oka T; Yasumura T
Transplant Proc; 1996 Jun; 28(3):1163-7. PubMed ID: 8658612
[No Abstract] [Full Text] [Related]
14. Impact of anti-hepatitis C virus (HCV) antibody on outcomes in renal transplant recipients infected with HCV.
Minz M; Sharma A; Das A; Chawla Y
Transplant Proc; 2008 Sep; 40(7):2386-8. PubMed ID: 18790242
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of HBsAg(+) renal allograft recipients.
Kang SW; Lee SW; Choi KH; Han KH; Lee HY; Han DS; Kim YS; Park K
Transplant Proc; 1996 Jun; 28(3):1653-4. PubMed ID: 8658823
[No Abstract] [Full Text] [Related]
16. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
[TBL] [Abstract][Full Text] [Related]
17. [Hepatitis C virus infection and clinical outcome of kidney transplantation].
Yu LX; Wang ZP; Fu SJ; Wang YB; Du CF; Xu J; Deng WF
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun; 24(6):682-4. PubMed ID: 15201089
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of kidneys from HCV-positive donors: a safe strategy?
Fabrizi F; Bunnapradist S; Lunghi G; Martin P
J Nephrol; 2003; 16(5):617-25. PubMed ID: 14733406
[TBL] [Abstract][Full Text] [Related]
19. Outcome of renal allograft in Turkish patients with pretransplantation hepatitis C virus infection.
Unal E; Turkmen F; Sevinc C; Kiziler AR; Aydemir B; Titiz I
Transplant Proc; 2006 Dec; 38(10):3448-50. PubMed ID: 17175299
[TBL] [Abstract][Full Text] [Related]
20. Natural history of hepatitis C virus infection in adult renal graft recipients.
Aroldi A; Lampertico P; Montagnino G; Lunghi G; Passerini P; Villa M; Campise M; Cesana BM; Ponticelli C
Transplant Proc; 2005 Mar; 37(2):940-1. PubMed ID: 15848581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
